125 related articles for article (PubMed ID: 1675609)
1. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors.
Millan MJ; Colpaert FC
Eur J Pharmacol; 1991 Feb; 193(2):145-52. PubMed ID: 1675609
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
3. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
5. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
Millan MJ; Bervoets K; Colpaert FC
Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
Hekmatpanah CR; Peroutka SJ
Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
10. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
Callaway CW; Rempel N; Peng RY; Geyer MA
Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
[TBL] [Abstract][Full Text] [Related]
12. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
13. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
Bervoets K; Millan MJ
J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
[TBL] [Abstract][Full Text] [Related]
15. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
Schmidt CJ; Sullivan CK; Fadayel GM
J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Nash JF; Meltzer HY; Gudelsky GA
J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
[TBL] [Abstract][Full Text] [Related]
17. When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists.
Rusyniak DE; Ootsuka Y; Blessing WW
Neuroscience; 2008 Jul; 154(4):1619-26. PubMed ID: 18534763
[TBL] [Abstract][Full Text] [Related]
18. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
Schmidt CJ; Black CK; Abbate GM; Taylor VL
Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
Schmidt CJ; Fadayel GM; Sullivan CK; Taylor VL
Eur J Pharmacol; 1992 Nov; 223(1):65-74. PubMed ID: 1362159
[TBL] [Abstract][Full Text] [Related]
20. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
Schmidt CJ; Abbate GM; Black CK; Taylor VL
J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
